Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

HELE

Helen of Troy Ltd

May 01 • 04:00PM ET

93.52

Dollar change +0.81
Percentage change 0.87	%

Consumer Defensive • Household & Personal Products • Bermuda • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VB IJH IWM VBR VXF IWN IJJ DFAT FNDA

Index	RUT	P/E	13.25	EPS (ttm)	7.06	Insider Own	1.31%	Shs Outstand	23.75M	Perf Week	3.10%
Market Cap	2.23B	Forward P/E	9.40	EPS next Y	9.95	Insider Trans	0.00%	Shs Float	23.50M	Perf Month	-15.53%
Income	168.59M	PEG	1.66	EPS next Q	1.60	Inst Own	111.88%	Short Float	14.77%	Perf Quarter	-18.32%
Sales	2.01B	P/S	1.11	EPS this Y	0.96%	Inst Trans	-3.40%	Short Ratio	12.91	Perf Half Y	-3.58%
Book/sh	68.94	P/B	1.36	EPS next Y	10.56%	ROA	5.86%	Short Interest	3.47M	Perf Year	-5.16%
Cash/sh	0.78	P/C	120.36	EPS next 5Y	8.00%	ROE	10.79%	52W Range	87.50 - 143.68	Perf YTD	-22.59%
Dividend Est.	-	P/FCF	8.26	EPS past 5Y	1.21%	ROI	7.22%	52W High	-34.91%	Beta	0.82
Dividend TTM	-	Quick Ratio	0.99	Sales past 5Y	5.60%	Gross Margin	47.09%	52W Low	6.88%	ATR (14)	3.52
Dividend Ex-Date	-	Current Ratio	1.87	EPS Y/Y TTM	18.42%	Oper. Margin	15.78%	RSI (14)	32.73	Volatility	3.11% 3.57%
Employees	1927	Debt/Eq	0.43	Sales Y/Y TTM	-2.77%	Profit Margin	8.41%	Recom	1.86	Target Price	132.30
Option/Short	Yes / Yes	LT Debt/Eq	0.43	EPS Q/Q	19.16%	Payout	0.00%	Rel Volume	2.10	Prev Close	92.71
Sales Surprise	2.12%	EPS Surprise	5.48%	Sales Q/Q	1.41%	Earnings	Apr 24 BMO	Avg Volume	268.80K	Price	93.52
SMA20	-6.09%	SMA50	-16.17%	SMA200	-18.83%	Trades		Volume	564,937	Change	0.87%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-17-23	Initiated	UBS	Neutral	$99
Dec-22-22	Upgrade	DA Davidson	Neutral → Buy	$115 → $126
Nov-17-22	Initiated	Canaccord Genuity	Buy	$120
Jul-13-22	Initiated	Raymond James	Mkt Perform
Feb-07-22	Upgrade	Sidoti	Neutral → Buy	$263
Mar-17-21	Downgrade	DA Davidson	Buy → Neutral	$247
Jan-28-21	Downgrade	Oppenheimer	Outperform → Perform
Jan-08-21	Downgrade	BofA Securities	Buy → Neutral	$235
Feb-06-20	Initiated	Oppenheimer	Outperform
Jul-10-19	Reiterated	BofA/Merrill	Buy	$160 → $165
May-08-19	Downgrade	Sidoti	Buy → Neutral
Jul-10-18	Upgrade	BofA/Merrill	Neutral → Buy	$127
Mar-29-18	Initiated	DA Davidson	Buy	$100
Sep-12-17	Initiated	CL King	Buy	$104
Aug-29-17	Initiated	BofA/Merrill	Underperform	$87
Dec-07-16	Downgrade	Piper Jaffray	Overweight → Neutral
Aug-19-16	Upgrade	Sidoti	Neutral → Buy
Mar-07-16	Initiated	Jefferies	Buy
Aug-25-15	Initiated	Sidoti	Neutral	$102
Apr-29-15	Upgrade	Piper Jaffray	Neutral → Overweight

Show Previous Ratings

Apr-26-24 09:40AM	Are Investors Undervaluing Helen of Troy (HELE) Right Now? (Zacks)
09:14AM	Helen of Troy Limited (NASDAQ:HELE) Q4 2024 Earnings Call Transcript (Insider Monkey)
Apr-25-24 11:53AM	Helen of Troy (HELE) Q4 Earnings Top Estimates, Sales Rise Y/Y (Zacks)
11:22AM	UBS Adjusts Helen of Troy Price Target to $100 From $121, Maintains Neutral Rating (MT Newswires)
Apr-24-24 03:49PM	Sector Update: Consumer Stocks Advance in Late Afternoon Trading (MT Newswires) -9.54%
01:49PM	Loading…
01:49PM	Sector Update: Consumer Stocks Higher in Afternoon Trading (MT Newswires)
11:54AM	HELE Stock Earnings: Helen Of Troy Beats EPS, Beats Revenue for Q4 2024 (InvestorPlace)
09:42AM	Helen of Troy's Fiscal Q4 Adjusted Earnings, Revenue Rise; Fiscal 2025 Outlook Issued (MT Newswires)
09:30AM	Helen of Troy (HELE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:03AM	Helen Of Troy Ltd (HELE) Q4 Earnings: Adjusted EPS Surpasses Analyst Expectations (GuruFocus.com)
07:04AM	Helen of Troy: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:45AM	Helen of Troy Limited Reports Solid Fourth Quarter Fiscal 2024 Results (Business Wire)
Apr-19-24 11:03AM	Helen of Troy (HELE) Q4 Earnings Coming Up: Factors to Note (Zacks)
Apr-03-24 04:05PM	Helen of Troy Limited Announces Earnings Release Date, Conference Call, and Webcast for Fourth Quarter and Fiscal Year 2024 Results (Business Wire)
Mar-28-24 01:38PM	15 Best Beauty Stocks To Invest In (Insider Monkey)
10:09AM	Loading…
Mar-26-24 10:09AM	Helen of Troy (HELE) Gains on Brand Strength & Investments (Zacks)
Mar-12-24 06:15PM	Helen of Troy (HELE) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Mar-06-24 06:15PM	Helen of Troy (HELE) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Feb-29-24 06:15PM	Helen of Troy (HELE) Stock Sinks As Market Gains: Here's Why (Zacks)
Feb-19-24 10:30AM	Helen of Troy (HELE) Benefits From Brand Strength & Project Pegasus (Zacks)
Feb-07-24 11:30AM	Helen of Troy (HELE) Down 8.2% Since Last Earnings Report: Can It Rebound? (Zacks)
Feb-06-24 09:21AM	11 Best Hair Care Stocks To Buy Now (Insider Monkey)
Jan-26-24 06:31PM	19 Best Reusable Water Bottles on Amazon Under $50 (Insider Monkey)
Jan-18-24 09:00AM	Hydro Flask's Parks For All Giving Program Commemorates 2024 Grantees (PR Newswire)
Jan-10-24 08:56AM	Helen of Troy Limited (NASDAQ:HELE) Q3 2024 Earnings Call Transcript (Insider Monkey)
Jan-09-24 08:19AM	Helen of Troy (HELE) Q3 Earnings Top Estimates, Sales Decline (Zacks)
Jan-08-24 04:03PM	Helen Of Troy Ltd Reports Mixed Fiscal Q3 Results Amidst Market Challenges (GuruFocus.com)
09:30AM	Helen of Troy (HELE) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
07:55AM	Helen of Troy (HELE) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:55AM	Helen of Troy: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:45AM	Loading…
06:45AM	Helen of Troy Limited Reports Third Quarter Fiscal 2024 Results (Business Wire)
Jan-03-24 04:05PM	Helen of Troy Limited Announces Participation in the 26th Annual ICR Conference (Business Wire) -5.24%
01:55PM	Things to Consider Before Helen of Troy's (HELE) Q3 Earnings (Zacks)
Dec-22-23 06:15PM	Helen of Troy (HELE) Outperforms Broader Market: What You Need to Know (Zacks)
Dec-18-23 04:05PM	Helen of Troy Limited Announces Earnings Release Date, Conference Call, and Webcast for Third Quarter Fiscal 2024 Results (Business Wire)
Dec-07-23 06:15PM	Helen of Troy (HELE) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Nov-30-23 06:15PM	Helen of Troy (HELE) Outpaces Stock Market Gains: What You Should Know (Zacks)
Nov-24-23 06:15PM	Why Helen of Troy (HELE) Outpaced the Stock Market Today (Zacks)
Nov-17-23 06:15PM	Why Helen of Troy (HELE) Outpaced the Stock Market Today (Zacks)
Nov-16-23 01:00PM	REVLON® HAIR TOOLS DELIVER TIME SAVING, AFFORDABLE AWARD-WINNING HOLIDAY GIFT SOLUTIONS (PR Newswire)
Nov-15-23 07:05AM	Bear Of The Day: Helen of Troy (HELE) (Zacks)
Nov-10-23 06:15PM	Helen of Troy (HELE) Outpaces Stock Market Gains: What You Should Know (Zacks)
Oct-25-23 10:30AM	Simply Good Foods (SMPL) Earnings Beat in Q4, Sales Rise Y/Y (Zacks)
Oct-24-23 08:59AM	Osprey Packs Broadens Technical Cycling Range with Innovative Entry Into Bikepacking Category (PR Newswire)
Oct-19-23 08:59AM	Osprey Packs Revolutionizes Everyday Carry with Archeon Collection Launch (PR Newswire)
Oct-18-23 08:59AM	Osprey Packs Celebrates 50 Years of Adventure with Special Edition Pack Launch (PR Newswire)
Oct-16-23 02:29PM	Hain Celestial (HAIN) Stock Plunges 38% in a Year: Here's Why (Zacks)
Oct-11-23 09:01AM	Osprey Continues to Make Significant Strides in Sustainability Efforts (PR Newswire)
Oct-10-23 08:59AM	Osprey Packs Unveils Dynamic Performance and Sustainable Design in 2024 Technical Line (PR Newswire)
Oct-09-23 09:00AM	Vicks Expands its Humidification Portfolio with VapoPads Sinus, Bringing Targeted Relief to Sinus and Allergy Sufferers (PR Newswire)
Oct-05-23 03:37PM	Tilray Brands (TLRY) Q1 Loss Wider, Revenues Increase Y/Y (Zacks)
01:21PM	Helen of Troy (HELE) Q2 Earnings Top Estimates, Reaffirms View (Zacks)
08:22AM	Helen of Troy Limited (NASDAQ:HELE) Q2 2024 Earnings Call Transcript (Insider Monkey)
Oct-04-23 03:30PM	Why Helen of Troy Stock Was Falling Today (Motley Fool) -7.36%
01:47PM	Rebel's Edge - October 4: $PLTR, $ATEN, $HELE, and the Twins In the Playoffs (TheStreet.com)
12:39PM	Helen Of Troy Ltd (HELE) Reports Q2 Fiscal 2024 Results: Net Sales Decline by 5. ... (GuruFocus.com)
12:14PM	RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023 (AP Finance)
12:05PM	Unveiling the Investment Potential of Helen Of Troy Ltd (HELE): A Comprehensive Analysis (GuruFocus.com)
11:44AM	Unveiling Helen Of Troy (HELE)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
10:30AM	Consumer Weakness Hurt These 2 Stocks. Is There More Pain to Come? (Motley Fool)
09:30AM	Helen of Troy (HELE) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
08:05AM	Helen of Troy (HELE) Q2 Earnings and Revenues Beat Estimates (Zacks)
08:00AM	Helen of Troy's Charts Show Their Age, and Its Latest Results Won't Help (TheStreet.com)
07:25AM	Helen Of Troy Q2 Results Top Estimates; Maintains FY24 Outlook; Confirms Brian Grass As CFO (RTT News)
06:57AM	Helen of Troy: Fiscal Q2 Earnings Snapshot (AP Finance)
06:45AM	Helen of Troy Limited Reports Second Quarter Fiscal 2024 Results (Business Wire)
Oct-03-23 03:15PM	We're Keeping an Eye on Portfolio Name Coty as Helen of Troy Reports (TheStreet.com)
09:20AM	Earnings Calendar Spotlight: High-Octane Chip Stock Expected To Report 300% Growth (Investor's Business Daily)
Sep-29-23 12:02PM	Things to Note Before Helen of Troy's (HELE) Q2 Earnings (Zacks)
Sep-26-23 06:15PM	Helen of Troy (HELE) Dips More Than Broader Markets: What You Should Know (Zacks)
Sep-22-23 11:40AM	HELE vs. ELF: Which Stock Is the Better Value Option? (Zacks)
Sep-21-23 12:26PM	Reasons Why You Should Avoid Betting on Sysco (SYY) Now (Zacks)
Sep-20-23 04:30PM	Helen of Troy Limited Announces Earnings Release Date, Conference Call, and Webcast for Second Quarter Fiscal 2024 Results (Business Wire)
Sep-19-23 01:04PM	The Estee Lauder Companies (EL) Dulls on Cost & Currency Woes (Zacks)
10:00AM	OXO® Unveils Stellar Lineup for Year Three of Its Chefs in Residence Program (PR Newswire)
Sep-18-23 05:09AM	Strength Seen in Inter Parfums (IPAR): Can Its 3.5% Jump Turn into More Strength? (Zacks)
Sep-12-23 06:15PM	Helen of Troy (HELE) Gains As Market Dips: What You Should Know (Zacks)
11:36AM	Helen of Troy (HELE) Gains on Brand Strength & Project Pegasus (Zacks)
Sep-08-23 08:53AM	Zacks Industry Outlook Highlights Coty, e.l.f. Beauty, Inter Parfums and Helen of Troy (Zacks)
Sep-07-23 08:05AM	4 Cosmetics Stocks Worth Watching Amid Industry Headwinds (Zacks)
Sep-06-23 06:15PM	Helen of Troy (HELE) Dips More Than Broader Markets: What You Should Know (Zacks)
11:40AM	HELE or ELF: Which Is the Better Value Stock Right Now? (Zacks)
09:00AM	PUR Unveils Exclusive, First-of-its-Kind Collaboration with Beautiful by Drew, Offering Cleaner Drinking Water in an Elegant New Way (PR Newswire)
Sep-01-23 10:47AM	Factors That Make Helen of Troy (HELE) an Attractive Bet Now (Zacks)
Aug-31-23 10:56AM	Campbell Soup (CPB) Q4 Earnings Meet Estimates, Sales Up Y/Y (Zacks)
Aug-30-23 09:40AM	Has e.l.f. Beauty (ELF) Outpaced Other Consumer Staples Stocks This Year? (Zacks)
Aug-28-23 06:15PM	Helen of Troy (HELE) Outpaces Stock Market Gains: What You Should Know (Zacks)
10:22AM	Buy SharkNinja Stock. Its a Gem Thats About To Be Discovered. (Barrons.com)
Aug-25-23 06:37PM	SharkNinja Reinvented the Ice Cream Maker. Its Stock Is a Buy. (Barrons.com)
Aug-24-23 11:28AM	Helen of Troy (HELE) Up More Than 20% in 3 Months: Here's Why (Zacks)
Aug-22-23 06:15PM	Helen of Troy (HELE) Dips More Than Broader Markets: What You Should Know (Zacks)
Aug-21-23 11:40AM	HELE vs. ELF: Which Stock Is the Better Value Option? (Zacks)
Aug-11-23 10:27AM	Helen of Troy (HELE) Poised on Leadership Brands, Strategies (Zacks) -5.52%
Aug-04-23 05:16AM	The Overwhelming Impact of Rising Rates on Helen of Troy Stock (Motley Fool)
Jul-31-23 02:51PM	Returns On Capital Signal Tricky Times Ahead For Helen of Troy (NASDAQ:HELE) (Simply Wall St.)
Jul-21-23 11:28AM	Helen of Troy (HELE) Up More Than 50% in 3 Months: Here's Why (Zacks)
Jul-19-23 09:40AM	Are Consumer Staples Stocks Lagging Helen of Troy (HELE) This Year? (Zacks)
08:30AM	If You Invested $1000 in Helen of Troy a Decade Ago, This is How Much It'd Be Worth Now (Zacks)
Jul-18-23 10:32AM	COTY Inks Agreement to Offload 3.6% of Its Stake in Wella (Zacks)
Jul-14-23 11:40AM	HELE or ELF: Which Is the Better Value Stock Right Now? (Zacks)

Helen of Troy Ltd. engages in the manufacture and distribution of personal care and household products. It operates through the Home and Outdoor, and Beauty and Wellness segments. The Home and Outdoor segment offers food preparation tools, containers, electronics, baby care, and cleaning products. The Beauty and Wellness segment develops and provides products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans. The company was founded by Gerald J. Rubin and Stanlee N. Rubin in 1968 and is headquartered in Hamilton, Bermuda.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grass Brian	Chief Financial Officer	May 11 '23	Buy	96.13	5,000	480,645	35,835	May 11 05:35 PM

Open in Screener

TXMD

TherapeuticsMD Inc

May 01 • 04:00PM ET

1.88

Dollar change +0.00
Percentage change 0.27	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWC

Index	-	P/E	-	EPS (ttm)	-1.00	Insider Own	3.68%	Shs Outstand	11.53M	Perf Week	-1.82%
Market Cap	21.73M	Forward P/E	-	EPS next Y	-	Insider Trans	-4.30%	Shs Float	11.11M	Perf Month	-16.04%
Income	-10.28M	PEG	-	EPS next Q	-	Inst Own	28.21%	Short Float	0.41%	Perf Quarter	-16.59%
Sales	1.30M	P/S	16.72	EPS this Y	-	Inst Trans	1.04%	Short Ratio	2.02	Perf Half Y	-8.94%
Book/sh	2.54	P/B	0.74	EPS next Y	-	ROA	-	Short Interest	0.05M	Perf Year	-44.88%
Cash/sh	0.38	P/C	5.02	EPS next 5Y	17.60%	ROE	-	52W Range	1.85 - 4.72	Perf YTD	-16.22%
Dividend Est.	-	P/FCF	-	EPS past 5Y	49.33%	ROI	-28.69%	52W High	-60.11%	Beta	1.07
Dividend TTM	-	Quick Ratio	1.38	Sales past 5Y	532.80%	Gross Margin	29.19%	52W Low	1.89%	ATR (14)	0.10
Dividend Ex-Date	-	Current Ratio	1.38	EPS Y/Y TTM	1.49%	Oper. Margin	-654.61%	RSI (14)	32.62	Volatility	3.30% 4.92%
Employees	1	Debt/Eq	0.27	Sales Y/Y TTM	-	Profit Margin	-789.40%	Recom	3.00	Target Price	5.00
Option/Short	Yes / Yes	LT Debt/Eq	0.22	EPS Q/Q	97.55%	Payout	-	Rel Volume	0.41	Prev Close	1.88
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-97.60%	Earnings	Mar 29 AMC	Avg Volume	22.74K	Price	1.88
SMA20	-5.35%	SMA50	-14.43%	SMA200	-30.18%	Trades		Volume	9,224	Change	0.27%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-07-20	Downgrade	Jefferies	Hold → Underperform
May-19-20	Downgrade	JP Morgan	Overweight → Neutral
Dec-02-19	Initiated	Guggenheim	Buy
Oct-17-19	Initiated	H.C. Wainwright	Buy	$7
Apr-30-19	Resumed	Noble Capital Markets	Outperform	$13
Jun-15-18	Initiated	JP Morgan	Overweight	$11
Sep-08-17	Initiated	Morgan Stanley	Equal-Weight	$6
Jul-11-17	Upgrade	Oppenheimer	Perform → Outperform
May-09-17	Downgrade	Oppenheimer	Outperform → Perform
Nov-22-16	Resumed	Jefferies	Buy	$18
Nov-22-16	Initiated	Oppenheimer	Outperform
Nov-07-16	Resumed	Guggenheim	Buy
Apr-04-16	Initiated	Goldman	Buy	$10
Dec-08-15	Reiterated	Stifel	Buy	$10 → $14
Dec-08-15	Reiterated	Jefferies	Buy	$15 → $18
Sep-21-15	Reiterated	Jefferies	Buy	$7 → $15
Jun-09-15	Initiated	Guggenheim	Buy
Jul-08-14	Initiated	FBR Capital	Outperform	$34
Apr-17-14	Reiterated	Noble Financial	Buy	$9 → $13
Jan-28-14	Reiterated	Noble Financial	Buy	$7.25 → $9

Show Previous Ratings

Mar-29-24 04:00PM	TherapeuticsMD Announces Full Year 2023 Financial Results (Business Wire)
Mar-12-24 11:40AM	25 Countries With Highest Abortion Rates (Insider Monkey) +6.95%
Jan-30-24 11:20PM	12 Best Prenatal Vitamins For Pregnant Women (Insider Monkey)
Nov-15-23 05:08AM	TherapeuticsMD: Q3 Earnings Snapshot (Associated Press Finance) +17.41%
Nov-14-23 04:05PM	TherapeuticsMD Announces Third Quarter 2023 Financial Results (Business Wire)
07:52AM	Loading…
Aug-14-23 07:52AM	TherapeuticsMD: Q2 Earnings Snapshot (Associated Press Finance)
06:50AM	TherapeuticsMD Announces Second Quarter 2023 Financial Results (Business Wire)
May-15-23 05:56PM	TherapeuticsMD: Q1 Earnings Snapshot (AP Finance)
04:05PM	TherapeuticsMD Announces First Quarter 2023 Financial Results (Business Wire)
Apr-14-23 12:00PM	All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy (Zacks)
Apr-07-23 04:01PM	TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition (Business Wire)
Jan-03-23 06:50AM	TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma (Business Wire) +11.81%
Dec-08-22 10:42AM	Boca pharma company will cut 212 employees after failed buyout (American City Business Journals)
Dec-04-22 06:00PM	TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma (Business Wire)
Nov-14-22 07:55PM	TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -7.45%
04:05PM	Loading…
04:05PM	TherapeuticsMD Announces Third Quarter 2022 Financial Results (Business Wire)
Oct-31-22 06:50AM	TherapeuticsMD Announces Additional $7 Million Private Placement (Business Wire) +6.21%
Oct-03-22 01:45PM	TherapeuticsMD receives $7M investment after merger plans unravel (American City Business Journals) -7.53%
06:50AM	TherapeuticsMD Announces $7 Million Private Placement (Business Wire)
Sep-12-22 06:50AM	TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers (Business Wire) +5.55%
Aug-15-22 01:00PM	TherapeuticsMD, Inc. (TXMD) Q2 2022 Earnings Call Transcript (Motley Fool)
08:05AM	TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:50AM	TherapeuticsMD Announces Second Quarter 2022 Financial Results (Business Wire)
Aug-08-22 06:50AM	TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022 (Business Wire)
Aug-01-22 01:00PM	Pharma firm receives $15M investment after canceled merger (American City Business Journals) +36.60%
06:50AM	TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital (Business Wire)
Jul-15-22 01:34PM	HC Wainwright Rating & Price Target On TherapeuticsMD Under Review On 'Unclear Path' (Benzinga) +12.50%
Jul-13-22 09:48AM	Why TherapeuticsMD Shares Are Sinking Today? (Benzinga) -35.55%
08:25AM	TherapeuticsMD's stock falls 41% after tender offer expires (MarketWatch)
06:50AM	TherapeuticsMD Announces Expiration of Tender Offer (Business Wire)
06:09AM	Loading…
Jul-06-22 06:09AM	EW Healthcare Partners Announces Extension of TherapeuticsMD Tender Offer (PR Newswire)
Jun-06-22 04:05PM	EW Healthcare Partners Announces Commencement of the Tender Offer for All Outstanding Shares of TherapeuticsMD (PR Newswire)
May-31-22 06:00AM	TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD (Business Wire) +364.02%
May-20-22 10:52AM	Why TherapeuticsMD Shares Are Trading Higher Today (Benzinga) +36.56%
09:43AM	TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA® (Business Wire)
May-16-22 08:00PM	TherapeuticsMD, Inc. (TXMD) Q1 2022 Earnings Call Transcript (Motley Fool)
05:45PM	TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	TherapeuticsMD Announces First Quarter 2022 Financial Results (Business Wire)
May-12-22 05:25PM	Harpoon Therapeutics, Inc. (HARP) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -13.87%
May-10-22 04:05PM	TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022 (Business Wire)
Apr-14-22 04:15PM	TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million (Business Wire)
Mar-10-22 01:30PM	TherapeuticsMD, Inc. (TXMD) Q4 2021 Earnings Call Transcript (Motley Fool) -27.50%
08:05AM	TherapeuticsMD (TXMD) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
06:50AM	TherapeuticsMD Announces Fourth Quarter 2021 Financial Results (Business Wire)
Mar-07-22 12:57PM	TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal (Benzinga) +43.05%
07:40AM	TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx (Business Wire)
Mar-01-22 04:30PM	TherapeuticsMD to Report Fourth Quarter 2021 Financial Results on March 10, 2022 (Business Wire) -5.69%
Feb-28-22 05:35PM	Nektar Therapeutics (NKTR) Reports Q4 Loss, Lags Revenue Estimates (Zacks) +8.28%
Feb-24-22 09:05AM	Radius Health (RDUS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Jan-25-22 08:52AM	TherapeuticsMD, Inc. (NASDAQ:TXMD): Is Breakeven Near? (Simply Wall St.)
Jan-06-22 07:29AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Jan-04-22 06:20AM	FDA Approves TherapeuticsMD's Low Dose Bijuva (Benzinga) +11.18%
Dec-28-21 09:53AM	Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options (Zacks)
Dec-13-21 06:08AM	TherapeuticsMD's Birth Control Med Receives FDA Response Letter To Revise Manufacturing Testing Limits (Benzinga) -11.51%
Dec-10-21 04:30PM	U.S. Food and Drug Administration (FDA) Responds to Request From TherapeuticsMD to Revise Certain Manufacturing Testing Limits for ANNOVERA® (Business Wire)
Dec-08-21 06:50AM	TherapeuticsMD Settles U.S. Patent Litigation with Amneal for BIJUVA® (Estradiol and Progesterone) Allowing for a May 25, 2032 Generic Entry Date (Business Wire)
Nov-24-21 07:54AM	TherapeuticsMD (NASDAQ:TXMD) investors are sitting on a loss of 90% if they invested five years ago (Simply Wall St.)
Nov-22-21 10:40AM	Therapeuticsmd Insider Trades $580K In Company Stock (Benzinga)
Nov-12-21 03:00AM	TherapeuticsMD, Inc. (TXMD) Q3 2021 Earnings Call Transcript (Motley Fool)
Nov-11-21 06:50AM	TherapeuticsMD Announces Third Quarter 2021 Financial Results (Business Wire) -7.82%
06:45AM	TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh ODowd, as Chief Executive Officer (Business Wire)
Nov-04-21 03:01PM	TherapeuticsMD (TXMD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Oct-27-21 05:00PM	TherapeuticsMD to Report Third Quarter 2021 Results on November 11, 2021 (Business Wire)
Oct-15-21 05:33PM	TherapeuticsMD Announces Appointment of Mark Glickman as Chief Business Officer (Business Wire)
Oct-05-21 01:28PM	What Type Of Shareholders Own The Most Number of TherapeuticsMD, Inc. (NASDAQ:TXMD) Shares? (Simply Wall St.)
Oct-04-21 09:20AM	Where Do Hedge Funds Stand On TherapeuticsMD Inc (TXMD)? (Insider Monkey)
Sep-02-21 06:50AM	Therapeutics MD Is Urging Women to Take Pause During Menopause Awareness Month (Business Wire) +7.71%
Aug-23-21 06:50AM	TherapeuticsMD Announces Issuance of a J-Code for ANNOVERA® to Be Utilized in the Public Health Sector (Business Wire) +7.12%
Aug-19-21 08:01AM	5 Penny Stocks Insiders Are Buying (Benzinga) +5.53%
Aug-09-21 04:30PM	TherapeuticsMD Announces Appointment of Hugh ODowd as President (Business Wire)
Aug-04-21 08:05AM	TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.66%
06:50AM	TherapeuticsMD Announces Second Quarter 2021 Financial Results (Business Wire)
Jul-28-21 03:03PM	Will TherapeuticsMD (TXMD) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-26-21 06:50AM	TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 (Business Wire)
Jul-06-21 11:49AM	10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman (Insider Monkey)
Jun-29-21 08:58AM	Breakeven On The Horizon For TherapeuticsMD, Inc. (NASDAQ:TXMD) (Simply Wall St.)
May-25-21 06:50AM	TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA (Business Wire)
May-24-21 07:00AM	The Sun Sentinel Names TherapeuticsMD, Inc. a Winner of the South Florida Top Workplaces 2021 Award (Business Wire)
May-07-21 01:31AM	TherapeuticsMD, Inc. (TXMD) Q1 2021 Earnings Call Transcript (Motley Fool)
May-06-21 10:56AM	TherapeuticsMD Shares Plunge On Declining Gross Margin, Total Prescription Volume (Benzinga) -13.28%
08:20AM	TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	TherapeuticsMD Announces First Quarter 2021 Financial Results (Business Wire)
06:45AM	TherapeuticsMD, Inc. to Host Earnings Call (ACCESSWIRE)
May-03-21 07:00AM	TherapeuticsMD Announces Poster Presentation of ANNOVERA® Data at the American College of Obstetricians and Gynecologists 2021 Annual Meeting (Business Wire)
Apr-29-21 10:34AM	TherapeuticsMD's (NASDAQ:TXMD) Shareholders Are Down 85% On Their Shares (Simply Wall St.)
07:00AM	TherapeuticsMD to Report First Quarter 2021 Results on May 6, 2021 (Business Wire)
Apr-28-21 12:34PM	TherapeuticsMD (TXMD) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
Apr-09-21 11:16AM	TXMD Stock: The News Giving TherapeuticsMD Shares a Shot in the Arm Friday (InvestorPlace)
05:05AM	TherapeuticsMD's Hormone Therapy Approved in U.K. and Belgium (TheStreet.com)
Apr-08-21 04:05PM	TherapeuticsMD and Theramex Announce the Approval of BIJUVE® Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA® in Belgium (Business Wire)
Mar-15-21 10:32AM	Here's What TherapeuticsMD, Inc.'s (NASDAQ:TXMD) Shareholder Ownership Structure Looks Like (Simply Wall St.)
Mar-02-21 07:00PM	TherapeuticsMD, Inc. (TXMD) Q4 2020 Earnings Call Transcript (Motley Fool)
08:25AM	TherapeuticsMD (TXMD) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:22AM	Recap: TherapeuticsMD Q4 Earnings (Benzinga)
07:00AM	TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results (Business Wire)
06:30AM	TherapeuticsMD, Inc. to Host Earnings Call (ACCESSWIRE)
Mar-01-21 10:05AM	TherapeuticsMD Earnings Preview (Benzinga)
07:00AM	TherapeuticsMD Announces Participation in Upcoming Investor Conferences (Business Wire)
Feb-23-21 04:05PM	TherapeuticsMD to Report Fourth Quarter 2020 Results on March 2, 2021 (Business Wire)
Feb-18-21 10:16AM	Here are the tough questions Congress needs to ask about GameStop today (Yahoo Finance Video) -5.41%

TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Walker Marlan D	Chief Executive Officer	Dec 07 '23	Sale	2.24	4,550	10,187	62,565	Dec 07 04:51 PM
Walker Marlan D	Chief Executive Officer	Dec 06 '23	Sale	2.31	14,500	33,496	67,115	Dec 07 04:51 PM
Walker Marlan D	Chief Executive Officer	Dec 05 '23	Option Exercise	0.00	70,000	0	81,615	Dec 07 04:51 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

HELE

Helen of Troy Ltd

TXMD

TherapeuticsMD Inc

Upgrade your FINVIZ experience